<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
59137-570-01
</NDCCode>
<PackageDescription>
1 AMPULE in 1 CARTON (59137-570-01) > 2 mL in 1 AMPULE
</PackageDescription>
<NDC11Code>
59137-0570-01
</NDC11Code>
<ProductNDC>
59137-570
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Hexatrione
</ProprietaryName>
<ProprietaryNameSuffix>
2%
</ProprietaryNameSuffix>
<NonProprietaryName>
Triamcinolone Hexacetonide
</NonProprietaryName>
<DosageFormName>
INJECTION, SUSPENSION
</DosageFormName>
<RouteName>
INTRA-ARTICULAR
</RouteName>
<StartMarketingDate>
20210303
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Medexus Pharma, Inc.
</LabelerName>
<SubstanceName>
TRIAMCINOLONE HEXACETONIDE
</SubstanceName>
<StrengthNumber>
40
</StrengthNumber>
<StrengthUnit>
mg/2mL
</StrengthUnit>
<Pharm_Classes>
Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2023-01-12
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20210303
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>